The cost‐effectiveness of testing for NS 5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) …
EH Elbasha, MN Robertson… - Alimentary …, 2017 - Wiley Online Library
Background The presence of baseline NS 5A resistance‐associated variants (RAV s)
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) …
EH Elbasha, MN Robertson… - Alimentary Pharmacology …, 2016 - europepmc.org
Background The presence of baseline NS5A resistance-associated variants (RAVs)
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) …
EH Elbasha, MN Robertson… - Alimentary …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The presence of baseline NS5A resistance-associated variants (RAVs)
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
[HTML][HTML] The cost‐effectiveness of testing for NS5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment …
EH Elbasha, MN Robertson… - Alimentary Pharmacology …, 2017 - ncbi.nlm.nih.gov
Background The presence of baseline NS 5A resistance‐associated variants (RAV s)
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
The cost-effectiveness of testing for NS5A resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) …
EH Elbasha, MN Robertson, C Nwankwo - 2017 - cabidigitallibrary.org
Background: The presence of baseline NS5A resistance-associated variants (RAVs)
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
The cost‐effectiveness of testing for NS 5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) …
EH Elbasha, MN Robertson, C Nwankwo - Alimentary Pharmacology & …, 2017 - infona.pl
Background The presence of baseline NS 5A resistance‐associated variants (RAV s)
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
impacted treatment response in HCV genotype 1a (GT 1a)‐infected patients treated with …
[PDF][PDF] The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naıve and treatment …
EH Elbasha, MN Robertson, C Nwankwo - 2016 - cyberleninka.org
Background The presence of baseline NS5A resistance-associated variants (RAVs)
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …
impacted treatment response in HCV genotype 1a (GT1a)-infected patients treated with …